Selected article for: "distribution volume and half life"
Title: 2016 ACVIM Forum Research Abstract Program
  • Document date: 2016_5_31
    • ID: 2y1y8jpx_631
    Snippet: After IV dosing, volume of distribution (V SS ) was 1.9 (0.3) L/kg (mean, std. deviation), terminal half-life (t½) was 39.4 (15.9) hours, and clearance was 28.1 (17.3) mL/kg/hr. After oral dosing, peak concentration (C MAX ) was 1.2 (0.5) µg/mL and terminal t½ was 38.1 (15.0) hours. Bioavailability from oral administration was 15.9% (8.6) . No adverse effects were observed from either route of administration......
    Document: After IV dosing, volume of distribution (V SS ) was 1.9 (0.3) L/kg (mean, std. deviation), terminal half-life (t½) was 39.4 (15.9) hours, and clearance was 28.1 (17.3) mL/kg/hr. After oral dosing, peak concentration (C MAX ) was 1.2 (0.5) µg/mL and terminal t½ was 38.1 (15.0) hours. Bioavailability from oral administration was 15.9% (8.6) . No adverse effects were observed from either route of administration.

    Search related documents:
    Co phrase search for related documents
    • administration route and half life: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • administration route and IV dose: 1, 2, 3
    • administration route and oral administration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • administration route and oral administration bioavailability: 1
    • administration route and oral dose: 1, 2
    • administration route and peak concentration: 1
    • adverse effect and half life: 1, 2
    • adverse effect and oral administration: 1, 2, 3
    • adverse effect and oral dose: 1, 2, 3
    • adverse effect and peak concentration: 1, 2
    • half life and IV dose: 1, 2, 3, 4, 5, 6, 7, 8
    • half life and oral administration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • half life and oral administration bioavailability: 1, 2
    • half life and oral dose: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • half life and peak concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • IV dose and oral administration: 1, 2
    • IV dose and oral dose: 1, 2, 3, 4, 5, 6, 7, 8
    • IV dose and peak concentration: 1
    • oral administration and peak concentration: 1, 2